TY - JOUR
T1 - Commercial influence and covid-19
AU - Moynihan, Ray
AU - Macdonald, Helen
AU - Bero, Lisa
AU - Godlee, Fiona
PY - 2020/6/24
Y1 - 2020/6/24
N2 - [Extract] Although the covid-19 pandemic has provoked the best of human compassion, the hallmarks of unhealthy commercial influence have also emerged. This week, The BMJ published the initial list of signatories to our call for action to reduce commercial influence in how healthcare evidence is produced and used (www.bmj.com/commercial-influence-call-to-action). Signatories include professors, patient advocates, clinicians, and researchers who want to see product evaluation, medical education, and clinical practice much freer from commercial interests.
AB - [Extract] Although the covid-19 pandemic has provoked the best of human compassion, the hallmarks of unhealthy commercial influence have also emerged. This week, The BMJ published the initial list of signatories to our call for action to reduce commercial influence in how healthcare evidence is produced and used (www.bmj.com/commercial-influence-call-to-action). Signatories include professors, patient advocates, clinicians, and researchers who want to see product evaluation, medical education, and clinical practice much freer from commercial interests.
UR - http://www.scopus.com/inward/record.url?scp=85087099516&partnerID=8YFLogxK
U2 - 10.1136/bmj.m2456
DO - 10.1136/bmj.m2456
M3 - Editorial
C2 - 32580930
SN - 0959-535X
VL - 369
JO - BMJ (Clinical research ed.)
JF - BMJ (Clinical research ed.)
M1 - m2456
ER -
